3.25
price down icon10.22%   -0.37
after-market 시간 외 거래: 3.80 0.55 +16.92%
loading
전일 마감가:
$3.62
열려 있는:
$3.65
하루 거래량:
274.35K
Relative Volume:
1.45
시가총액:
$2.60M
수익:
-
순이익/손실:
$-4.21M
주가수익비율:
-59.31
EPS:
-0.0548
순현금흐름:
-
1주 성능:
-6.61%
1개월 성능:
-61.31%
6개월 성능:
-97.97%
1년 성능:
-99.93%
1일 변동 폭
Value
$3.21
$3.75
1주일 범위
Value
$3.21
$4.39
52주 변동 폭
Value
$3.21
$4,680.00

Conduit Pharmaceuticals Inc Stock (CDT) Company Profile

Name
명칭
Conduit Pharmaceuticals Inc
Name
전화
(646) 491 9132
Name
주소
4851 TAMIAMI TRAIL NORTH, NAPLES
Name
직원
6
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CDT's Discussions on Twitter

CDT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CDT
Conduit Pharmaceuticals Inc
3.25 2.78M 0 -4.21M 0 -0.0548
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Conduit Pharmaceuticals Inc 주식(CDT)의 최신 뉴스

pulisher
May 30, 2025

CDT stock plunges to 52-week low, hitting $3.21 amid steep decline - Investing.com UK

May 30, 2025
pulisher
May 27, 2025

Conduit Pharmaceuticals regains Nasdaq compliance - MSN

May 27, 2025
pulisher
May 23, 2025

Conduit Pharmaceuticals receives approval for Nasdaq listing - MSN

May 23, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals approved to transfer listing to Nasdaq Capital Market - TipRanks

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals moves to Nasdaq Capital Market By Investing.com - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23 - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals moves to Nasdaq Capital Market - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan

May 22, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals meets Nasdaq listing standards By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals meets Nasdaq listing standards - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Regains Compliance With Nasdaq's Bid Price, Equity Requirements - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Inc. Regains Compliance with Nasdaq Listing Requirements - Nasdaq

May 21, 2025
pulisher
May 21, 2025

Conduit Pharmaceuticals Secures Future on Nasdaq: Clears Both Bid Price and Equity Hurdles - Stock Titan

May 21, 2025
pulisher
May 19, 2025

Upcoming Stock Splits This Week (May 19 to May 23) – Stay Invested - The Globe and Mail

May 19, 2025
pulisher
May 19, 2025

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic - Asianet Newsable

May 19, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals approves reverse stock split By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic By Stocktwits - Investing.com India

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Announces Reverse Stock Split - TipRanks

May 16, 2025
pulisher
May 16, 2025

Barclays PLC Buys 54,523 Shares of Conduit Pharmaceuticals Inc. (NASDAQ:CDT) - Defense World

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - The Manila Times

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals approves reverse stock split - Investing.com

May 16, 2025
pulisher
May 16, 2025

Conduit Pharmaceuticals Inc. Announces 1-for-15 Reverse Stock Split Approval - Nasdaq

May 16, 2025
pulisher
May 15, 2025

CONDUIT PHARMACEUTICALS INC. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 15, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases - The Manila Times

May 09, 2025
pulisher
May 09, 2025

Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Advancing Global Development Strategy for Autoimmune Disorders - Nasdaq

May 09, 2025
pulisher
May 08, 2025

Conduit Pharmaceuticals Files New Patent For AZD5904 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

In 2025, Will Conduit Pharmaceuticals Inc (NASDAQ: CDT) Be Bullish Or Bearish? - Stocksregister

May 08, 2025
pulisher
May 08, 2025

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset - The Manila Times

May 08, 2025
pulisher
May 06, 2025

Conduit Pharmaceuticals Approves Reverse Stock Split Amendments - TipRanks

May 06, 2025
pulisher
May 06, 2025

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Shares Acquired by Geode Capital Management LLC - Defense World

May 06, 2025
pulisher
May 02, 2025

Conduit Pharmaceuticals Inc (CDT)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

May 02, 2025
pulisher
May 01, 2025

Short Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Increases By 98.5% - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Keeping an Eye on Conduit Pharmaceuticals Inc (CDT) After Insider Trading Activity - knoxdaily.com

Apr 30, 2025
pulisher
Apr 28, 2025

Conduit Pharmaceuticals Inc (CDT)’s Day in Review: Closing at 0.56, Up by 4.07 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Investor’s Delight: Conduit Pharmaceuticals Inc (CDT) Closes Weak at 0.65, Down -5.79 - DWinneX

Apr 27, 2025
pulisher
Apr 25, 2025

Conduit Pharmaceuticals (NASDAQ:CDT) Stock Price Down 2.9% – Time to Sell? - Defense World

Apr 25, 2025
pulisher
Apr 23, 2025

What Do Wall Street Analysts Think About Conduit Pharmaceuticals Inc (NASDAQ: CDT) Stock? - Stocksregister

Apr 23, 2025
pulisher
Apr 23, 2025

Conduit Pharmaceuticals files to sell 2.1M shares of common stock for holders - MSN

Apr 23, 2025
pulisher
Apr 22, 2025

Conduit Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 22, 2025
pulisher
Apr 21, 2025

Are Conduit Pharmaceuticals Inc (CDT) shares a good deal now? - uspostnews.com

Apr 21, 2025
pulisher
Apr 21, 2025

Market Resilience: Conduit Pharmaceuticals Inc (CDT) Finishes Weak at 0.62, Down -20.51 - DWinneX

Apr 21, 2025
pulisher
Apr 21, 2025

CDT’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Apr 21, 2025
pulisher
Apr 16, 2025

CDTConduit Pharms Latest Stock News & Market Updates - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

Conduit Pharmaceuticals Announces Leadership Changes - marketscreener.com

Apr 16, 2025

Conduit Pharmaceuticals Inc (CDT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):